Oral submucous fibrosis (OSF), a potentially malignant disorder frequently linked to areca nut chewing, predisposes patients to a particular subtype of OSCC known as ODSCC (oral squamous cell carcinoma derived from OSF). This particular lineage of cancer cells appears to create a more hostile and immune-evasive microenvironment, setting it apart from OSCCs without OSF history (termed NODSCC). While previous studies have evaluated the molecular and metabolic landscapes of ODSCC, the precise cellular players driving the immunosuppressive network remained elusive until now.

Employing state-of-the-art single-cell RNA sequencing (scRNA-seq) coupled with spatial transcriptomics (ST) techniques, Zhao and colleagues performed a deep dissection of the tumor microenvironment (TME) in ODSCC. By analyzing publicly available GEO database datasets alongside multiple immunofluorescence staining, they delineated the complex cellular crosstalk that supports tumor progression and immune evasion. Their findings indicate a pivotal elevation of exhausted CD8+ T cells and regulatory T cells (Tregs), which suppress effective anti-tumor immunity, paired with a marked reduction in cytotoxic T lymphocytes — the frontline soldiers of tumor eradication.

A critical discovery within this study is the enrichment of macrophages expressing Inhibin subunit beta A (INHBA), termed INHBA+ macrophages, which are prominently elevated in ODSCC compared to NODSCC. These macrophages display the strongest immune suppressive signatures, including heightened immune checkpoint molecule activity, diminished major histocompatibility complex (MHC) expression, and increased levels of SPP1, a marker closely associated with tumor-promoting functions. Importantly, INHBA+ macrophages sourced from ODSCC exhibit more pronounced immunosuppressive properties than those from NODSCC, suggesting a microenvironment finely tuned to thwart immune surveillance.

Alongside these macrophages, the study identified proinflammatory cancer-associated fibroblasts (iCAFs) as another major contributor to the unique tumor ecology of ODSCC. These iCAFs express higher levels of INHBA, while also being enriched in pathways related to immune modulation and extracellular matrix remodeling. Crucially, iCAFs in ODSCC express genes like TDO2, IDO1, and DUSP4 at significantly elevated levels compared to NODSCC. These genes are implicated in creating an immunosuppressive microenvironment through the catabolism of tryptophan and immune signaling regulation, collectively dampening the immune system’s ability to attack tumor cells effectively.

The researchers also spotlighted how INHBA expression is not only prevalent within immune and stromal cells but can be induced by arecoline, a principal alkaloid found in areca nuts frequently chewed in regions endemic to OSF. In vitro experiments utilizing THP-1 macrophage-like cells demonstrated that arecoline stimulation dramatically increases INHBA expression. This result bridges a direct causative link between lifestyle risk factors and molecular changes underpinning tumor immune evasion.

Integration of spatial transcriptomics revealed a localized co-distribution of INHBA+ macrophages, iCAFs, and Tregs within the TME. This physical proximity suggests that these cell subsets engage in intimate paracrine interactions that sculpt an immunosuppressive niche. Further computational analyses pinpointed specific molecular interactions involving INHBA and its receptors ACVR1, ACVR2A, and ACVR2B in regions where these immune and stromal cells converge, inferring a potential signaling axis modulating Treg differentiation and functional activity.

From a translational perspective, the heightened presence of INHBA+ macrophages and iCAFs in ODSCC likely manifests as a more severe tumor immunosuppressive microenvironment (TISME), which could explain why patients with this subtype show poorer responses to immune checkpoint blockade therapies. This insight not only emphasizes the need to customize immunotherapy regimens considering tumor origin and microenvironment but also identifies INHBA and its associated signaling pathways as promising therapeutic targets.

The comprehensive multi-omics approach deployed in this study underscores the necessity of understanding tumor biology at a single-cell resolution, particularly within spatial contexts. By navigating the complex heterogeneity of tumor-infiltrating immune and stromal cells, the researchers have illuminated a heretofore unappreciated architectural framework of the ODSCC microenvironment that confers immune privilege and supports cancer progression.

Outside of immune evasion, the enhanced expression of collagen and extracellular matrix components orchestrated by iCAFs suggests these fibroblasts also contribute to the physical remodeling of the tumor niche, which may further impede immune cell infiltration. This combination of biochemical and biomechanical immunosuppressive modalities paints a sophisticated portrait of tumor-host interactions in OSF-related OSCC.

Furthermore, the coupling of environmental exposure (arecoline) to molecular shifts within the TME highlights the multifaceted drivers of tumor evolution in specific populations. This offers crucial insights for preventative interventions aimed at diminishing OSF incidence, potentially reducing subsequent malignancies with refractory immune microenvironments.

Beyond its immediate clinical relevance, the study opens new avenues for mechanistic exploration of TGF-β family signaling, given INHBA’s role as a member of this superfamily. Understanding how INHBA-ACVR receptor complexes specifically modulate immune cell phenotypes may reveal novel checkpoints for modulating immunosuppression that can be pharmacologically exploited in OSCC and other solid tumors.

In summary, this pioneering research delineates a richly detailed immune-stromal landscape in ODSCC defined by INHBA+ macrophages and pro-inflammatory CAFs that foster a uniquely suppressive microenvironment. The findings not only deepen comprehension of OSF-derived OSCC pathobiology but also carry impactful translational implications for biomarker development and rational design of combination therapies targeting the immunosuppressive network.

As immunotherapy continues to transform oncology, studies like Zhao et al.’s serve as a reminder that the microenvironment’s cellular choreography can decisively influence treatment outcomes. By unraveling the complexity of tumor-immune crosstalk in OSF-related cancers, science edges closer to therapies tailored to surmount immune escape and improve prognosis for patients burdened by this challenging disease.

—

Subject of Research: Distinctive immunosuppressive tumor microenvironment in submucous fibrosis-derived oral squamous cell carcinoma characterized by INHBA-positive macrophages and pro-inflammatory cancer-associated fibroblasts.

Article Title: INHBA⁺ macrophages and Pro-inflammatory CAFs are associated with distinctive immunosuppressive tumor microenvironment in submucous Fibrosis-Derived oral squamous cell carcinoma

Article References:
Zhao, S., Zhang, Y., Meng, X. et al. INHBA⁺ macrophages and Pro-inflammatory CAFs are associated with distinctive immunosuppressive tumor microenvironment in submucous Fibrosis-Derived oral squamous cell carcinoma. BMC Cancer 25, 857 (2025). https://doi.org/10.1186/s12885-025-14261-2

Image Credits: Scienmag.com

DOI: https://doi.org/10.1186/s12885-025-14261-2

This investigation, published in the latest issue of BMC Cancer, ventures beyond the conventional understanding of carcinogen exposure by integrating molecular genetics to unveil novel biomarkers that could revolutionize early detection and risk stratification. The research team conducted a robust case-control study encompassing 428 lung cancer patients juxtaposed with an equal number of cancer-free controls, meticulously genotyping six single-nucleotide polymorphisms (SNPs) associated with glycosyltransferase enzymes: FUT2 rs1047781, FUT2 rs601338, FUT3 rs28362459, FUT3 rs3745635, ST6Gal-I rs2239611, and MGAT5 rs34944508.

What distinguishes this study is its focus on the synergistic influence of lifestyle habits—specifically areca nut chewing, a known Group 1 carcinogen as per the International Agency for Research on Cancer (IARC)—and genetic variants influencing protein glycosylation pathways. Glycosylation, the enzymatic process of adding sugar moieties to proteins and lipids, plays a pivotal role in cellular recognition, signaling, and immune response modulation; aberrations in this mechanism have been implicated in cancer progression and metastasis.

Among the SNPs analyzed, the ST6Gal-I rs2239611 polymorphism emerged as a significant genetic marker correlated with increased lung cancer risk. Individuals harboring the AA genotype at this locus displayed more than twice the adjusted odds of developing lung cancer compared to other genotypes (adjusted OR = 2.077). This genotype’s influence was pronounced particularly among smokers and alcohol consumers, underscoring a critical gene-environment interaction that amplifies carcinogenic vulnerability.

Equally compelling were findings surrounding the FUT2 rs1047781 variant. While not directly increasing baseline cancer risk, this polymorphism exhibited strong associations with higher clinical staging and lymph node metastasis in lung cancer patients, suggesting a role in tumor progression dynamics. Importantly, it also demonstrated significant interaction with behavioral carcinogens, most notably with betel quid (areca nut) chewing, further potentiating malignancy risk.

The methodological rigor employed through MassARRAY genotyping technology bolstered the precision of identifying SNP variations, enabling granular analysis of their contributions to lung carcinogenesis. Logistic regression models accounted for confounders and elucidated the modified effects of behavioral exposures, affirming that neither genetic nor environmental factors act in isolation. Instead, it is their confluence that appears instrumental in modulating lung cancer susceptibility.

These revelations hold profound clinical implications. First, ST6Gal-I rs2239611 qualifies as a promising genetic biomarker for identifying individuals at heightened risk, particularly in populations where smoking, alcohol consumption, and areca nut use converge. Early genetic screening could inform personalized preventive strategies and targeted surveillance. Second, the synergistic carcinogenicity of combined lifestyle risk factors accentuates the urgency for comprehensive public health interventions focusing on behavioral modification in endemic regions.

Notably, the inclusion of areca nut—a culturally prevalent substance primarily studied in relation to oral cancers—marks a novel expansion into lung cancer etiology. This recognition of areca nut’s interaction with genetic predisposition in lung tissue carcinogenesis introduces new avenues for research exploring its systemic effects and mechanistic pathways underlying glycosylation-mediated tumor promotion.

The study navigates uncharted territory in cancer genomics where post-translational modifications intersect with complex gene-environment circuits, enriching our understanding of tumor biology. Glycosyltransferases such as FUT2 and ST6Gal-I, responsible for fucosylation and sialylation respectively, modulate cell surface glycan patterns influencing cell adhesion, immune evasion, and metastatic potential. Polymorphic alterations in these enzymes may disrupt these processes, facilitating malignant transformation under environmental carcinogen pressure.

Moreover, these findings accentuate the heterogeneity inherent in lung cancer pathogenesis across different ethnic and geographic populations. The Hainan cohort’s unique exposure profile underscores the necessity for context-specific investigations, as genetic and behavioral risk interactions might vary extensively worldwide, impacting global lung cancer prevention strategies.

As lung cancer continues to claim millions of lives globally, insights from this study underscore the importance of integrated genomic and environmental risk profiling. Such knowledge empowers precision medicine approaches aimed at mitigating disease burden through individualized risk assessments that incorporate genetic susceptibilities and lifestyle factors.

Future research trajectories may include functional assays to elucidate the mechanistic underpinnings by which ST6Gal-I and FUT2 variants influence tumor microenvironments and metastatic cascades. Additionally, expanding SNP panels and incorporating epigenetic analyses could unravel more layers of complexity, refining predictive models and therapeutic targets.

In conclusion, this pioneering research illuminates the critical nexus where genetic polymorphisms of glycosyltransferase enzymes and modifiable behavioral exposures intersect to heighten lung cancer risk. It delivers a compelling argument for revising current paradigms, advocating for multidisciplinary strategies that combine genetic screening with proactive lifestyle interventions—especially in high-risk regions with prevalent areca nut usage. The potential to reduce lung cancer incidence by understanding and interrupting these synergistic mechanisms heralds a new frontier in cancer prevention and personalized care.

Subject of Research: The combined influence of glycosyltransferase gene polymorphisms and behavioral factors (areca nut chewing, cigarette smoking, alcohol consumption) on lung cancer risk.

Article Title: Combined effect of areca nut, cigarettes, alcohol and SNPs in glycosyltransferase family genes on lung cancer development in Hainan, China

Article References:
Kuang, S., Xiao, S., Zhou, J. et al. Combined effect of areca nut, cigarettes, alcohol and SNPs in glycosyltransferase family genes on lung cancer development in Hainan, China. BMC Cancer 25, 814 (2025). https://doi.org/10.1186/s12885-025-14088-x

Image Credits: Scienmag.com

DOI: https://doi.org/10.1186/s12885-025-14088-x